SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-22-000026
Filing Date
2022-05-09
Accepted
2022-05-09 16:22:57
Documents
13
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20220509x8k.htm   iXBRL 8-K 113954
2 EX-99.1 amph-20220509xex99d1.htm EX-99.1 483267
  Complete submission text file 0001297184-22-000026.txt   745646

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20220509.xsd EX-101.SCH 3210
4 EX-101.LAB amph-20220509_lab.xml EX-101.LAB 15497
5 EX-101.PRE amph-20220509_pre.xml EX-101.PRE 10521
7 EXTRACTED XBRL INSTANCE DOCUMENT amph-20220509x8k_htm.xml XML 4641
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 22905380
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences